Dianthus Therapeutics, Inc.
DNTH
$43.97
$1.694.00%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 402.61M | 257.39M | 263.23M | 275.24M | 281.12M |
| Total Receivables | 5.00M | 39.00K | 1.00M | 807.00K | 2.68M |
| Inventory | 3.84M | 3.94M | 4.31M | 3.04M | 2.68M |
| Prepaid Expenses | 2.30M | 2.12M | 2.07M | 1.47M | 1.01M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 73.00K | 111.00K | 392.00K | 355.00K | -- |
| Total Current Assets | 413.83M | 263.61M | 271.00M | 280.90M | 287.49M |
|
|
|||||
| Total Current Assets | 413.83M | 263.61M | 271.00M | 280.90M | 287.49M |
| Net Property, Plant & Equipment | 1.49M | 1.59M | 1.64M | 1.75M | 541.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 8.85M | 9.18M | 7.64M | 9.63M | 4.43M |
| Total Assets | 577.45M | 326.08M | 348.58M | 374.01M | 354.25M |
|
|
|||||
| Total Accounts Payable | 6.71M | 5.40M | 8.27M | 4.58M | 7.57M |
| Total Accrued Expenses | 15.98M | 14.00M | 7.98M | 13.07M | 7.73M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 217.00K | 211.00K | 226.00K | 320.00K | 311.00K |
| Total Finance Division Other Current Liabilities | 954.00K | 479.00K | 479.00K | 479.00K | 100.00K |
| Total Other Current Liabilities | 954.00K | 479.00K | 479.00K | 479.00K | 100.00K |
| Total Current Liabilities | 23.86M | 20.09M | 16.95M | 18.45M | 15.71M |
|
|
|||||
| Total Current Liabilities | 23.86M | 20.09M | 16.95M | 18.45M | 15.71M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1.07M | 1.12M | 1.17M | 1.17M | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 6.07M | 1.79M | 1.85M | 1.91M | 640.00K |
| Total Liabilities | 30.99M | 23.00M | 19.97M | 21.53M | 16.35M |
|
|
|||||
| Common Stock & APIC | 818.59M | 538.51M | 532.24M | 526.76M | 483.17M |
| Retained Earnings | -272.30M | -235.53M | -203.90M | -174.39M | -145.95M |
| Treasury Stock & Other | 163.00K | 98.00K | 270.00K | 106.00K | 681.00K |
| Total Common Equity | 546.45M | 303.08M | 328.61M | 352.48M | 337.90M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 546.45M | 303.08M | 328.61M | 352.48M | 337.90M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 546.45M | 303.08M | 328.61M | 352.48M | 337.90M |
|
|
|||||